nimodipine has been researched along with 2019 Novel Coronavirus Disease in 2 studies
Nimodipine: A calcium channel blockader with preferential cerebrovascular activity. It has marked cerebrovascular dilating effects and lowers blood pressure.
nimodipine : A dihydropyridine that is 1,4-dihydropyridine which is substituted by methyl groups at positions 2 and 6, a (2-methoxyethoxy)carbonyl group at position 3, a m-nitrophenyl group at position 4, and an isopropoxycarbonyl group at position 5. An L-type calcium channel blocker, it acts particularly on cerebral circulation, and is used both orally and intravenously for the prevention and treatment of subarachnoid hemorrhage from ruptured intracranial aneurysm.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Pediatric stroke is considered an infrequent complication of COVID-19." | 1.72 | Clinical improvement of a toddler with COVID-19 focal cerebral arteriopathy possibly due to intra-arterial nimodipine. ( Aharoni, S; Auriel, E; Avital, D; Bulkowstein, Y; Inbar, E; Konen, O; Nahum, E; Nevo, Y; Peretz, S; Perlow, E; Straussberg, R; Vig, LC, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Avital, D | 1 |
| Peretz, S | 1 |
| Perlow, E | 1 |
| Konen, O | 1 |
| Inbar, E | 1 |
| Bulkowstein, Y | 1 |
| Nahum, E | 1 |
| Aharoni, S | 1 |
| Vig, LC | 1 |
| Nevo, Y | 1 |
| Auriel, E | 1 |
| Straussberg, R | 1 |
| Mansoor, T | 1 |
| Alsarah, AA | 1 |
| Mousavi, H | 1 |
| Khader Eliyas, J | 1 |
| Girotra, T | 1 |
| Hussein, O | 1 |
2 other studies available for nimodipine and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Clinical improvement of a toddler with COVID-19 focal cerebral arteriopathy possibly due to intra-arterial nimodipine.
Topics: Cerebral Arterial Diseases; Child; Child, Preschool; COVID-19; Humans; Nimodipine; SARS-CoV-2; Strok | 2022 |
COVID-19 Associated Reversible Cerebral Vasoconstriction Syndrome Successfully Treated with Nimodipine and Aspirin.
Topics: Adult; Aspirin; Cerebral Arteries; COVID-19; Female; Humans; Nimodipine; Syndrome; Treatment Outcome | 2021 |